Factor XIII Activity
2006182
 
Ordering Recommendation
First-line test to diagnose FXIII deficiency. Appropriate for evaluation of patients with a bleeding disorder present with normal PT, PTT, and platelet count test results. Use for monitoring FXIII therapy and for confirming abnormalities detected on FXIII qualitative assay.
Mnemonic
F13 A
Methodology
Chromogenic Assay
Performed
Wed
Reported
1-8 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
 
Collect
Lt. blue (sodium citrate). Refer to Specimen Handling at www.aruplab.com for hemostasis/thrombosis specimen handling guidelines.  
Specimen Preparation
Transfer 2 mL platelet-poor plasma to an ARUP Standard Transport Tube. (Min: 1 mL)  
Storage/Transport Temperature
CRITICAL FROZEN. Separate specimens must be submitted when multiple tests are ordered.  
Unacceptable Conditions
Serum. Non-frozen specimens. Hemolyzed specimens. Wrong anticoagulant (non-sodium citrated plasma).  
Remarks
 
Stability
Ambient: 4 hours; Refrigerated: Unacceptable; Frozen: at -20°C or below: 1 month; Frozen at -70°C or below: 3 months  
Reference Interval
Factor XIII Activity 69-143%
Interpretive Data
Refer to Statement B under Testing Information at http://www.aruplab.com.

See Compliance Statement D: www.aruplab.com/CS
Note
CPT Code(s)
85290
Components
Component Test Code*Component Chart Name
2006183Factor XIII Activity
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, contact interface support at interface.support@aruplab.com.
Cross References
  • Factor 13
  • fibrin stabilizing factor